Antipsychotic prescribing for Alzheimer’s disease and related disorders in specialized settings from 2010 to 2014 in France: a repeated cross-sectional study
Abstract Background Safety warnings from health authorities are currently intended to limit the use of antipsychotics (APs) in dementia-related conditions to treat neuropsychiatric symptoms, such as disturbing and/or delusional behaviors. The aim of this study is to investigate prevalence, correlate...
Main Authors: | Karim Tifratene, Valeria Manera, Roxane Fabre, Auriane Gros, Susanne Thummler, Christian Pradier, Philippe Robert, Renaud David |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-04-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13195-017-0256-8 |
Similar Items
-
Antipsychotics in Alzheimer's disease: A critical analysis
by: Eduardo Marques da Silva, et al. -
Development of a tool for monitoring the prescribing of antipsychotic medications to people with dementia in general practice: a modified eDelphi consensus study
by: Jennings AA, et al.
Published: (2018-10-01) -
Potentially Inappropriate Prescriptions of Antipsychotics for Patients With Dementia
by: Manuel Enrique Machado-Duque, et al.
Published: (2021-05-01) -
Use of Antipsychotic Medications in Individuals With Alzheimer's Disease in Nursing Facilities
by: Dionne-Vahalik, Michelle M
Published: (2018) -
Quality of opioid prescribing in older adults with or without Alzheimer disease and related dementia
by: Yu-Jung Jenny Wei, et al.
Published: (2021-04-01)